Molecular Cancer Research Folkman AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, L.
Right arrow Articles by Quelle, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, L.
Right arrow Articles by Quelle, D. E.
Molecular Cancer Research 1:195-206 (2003)
© 2003 American Association for Cancer Research


Cell Cycle, Cell Death, and Senescence

Cyclin G1 Has Growth Inhibitory Activity Linked to the ARF-Mdm2-p53 and pRb Tumor Suppressor Pathways1

Lili Zhao1, Tina Samuels1, Sarah Winckler1, Chandrashekhar Korgaonkar1, Van Tompkins1, Mary C. Horne1,2 and Dawn E. Quelle1,2

1 Department of Pharmacology and 2 The Molecular Biology Graduate Program, College of Medicine, The University of Iowa, Iowa City, IA

Requests for reprints: Dawn E. Quelle, Department of Pharmacology, College of Medicine, The University of Iowa, 51 Newton Road, Iowa City, IA 52242. Phone: (319) 353-5749; Fax: (319) 335-8930. E-mail: dawn-quelle{at}uiowa.edu

Cyclin G1 is a p53-responsive gene that is induced in alternative reading frame (ARF)-arrested cells, yet its role in growth control is unclear. We tested its effects on growth and involvement in the ARF-Mdm2-p53 tumor suppressor pathway. We show that cyclin G1 interacts with ARF, Mdm2, and p53 in vitro and in vivo. At high levels, cyclin G1 induces a G1-phase arrest in mammalian cells that coincides with p53 activation. Conversely, lower levels of cyclin G1 lack intrinsic growth inhibitory effects yet potentiate ARF-mediated growth arrest. Notably, cyclin G1 is down-regulated by Mdm2 through proteasome-mediated degradation. These data suggest that cyclin G1 is a positive feedback regulator of p53 whose expression is restrained by Mdm2. Interestingly, growth inhibition by cyclin G1 does not require p53 but instead exhibits partial retinoblastoma protein (pRb) dependence. These findings reveal that cyclin G1 has growth inhibitory activity that is mechanistically linked to ARF-p53 and pRb tumor suppressor pathways.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. M. Piscopo and P. W. Hinds
A Role for the Cyclin Box in the Ubiquitin-Mediated Degradation of Cyclin G1
Cancer Res., July 15, 2008; 68(14): 5581 - 5590.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S.-H. Kwon, J.-C. Park, S. Ramachandran, S.-D. Cha, K.-Y. Kwon, J.-K. Park, J.-W. Park, I. Bae, and C.-H. Cho
Loss of Cyclin G1 Expression in Human Uterine Leiomyoma Cells Induces Apoptosis
Reproductive Sciences, April 1, 2008; 15(4): 400 - 410.
[Abstract] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X.-F. Le, A. S. Arachchige-Don, W. Mao, M. C. Horne, and R. C. Bast Jr.
Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells
Mol. Cancer Ther., November 1, 2007; 6(11): 2843 - 2857.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Liu, Z. Liu, S.-W. Jang, Z. Ma, K. Shinmura, S. Kang, S. Dong, J. Chen, K. Fukasawa, and K. Ye
Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival
PNAS, June 5, 2007; 104(23): 9679 - 9684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Tompkins, J. Hagen, A. A. Frazier, T. Lushnikova, M. P. Fitzgerald, A. di Tommaso, V. Ladeveze, F. E. Domann, C. M. Eischen, and D. E. Quelle
A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability
J. Biol. Chem., January 12, 2007; 282(2): 1322 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ohkubo, T. Tanaka, Y. Taya, K. Kitazato, and C. Prives
Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription
J. Biol. Chem., June 23, 2006; 281(25): 16943 - 16950.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Chen, H. Ruan, S. M. Ng, C. Gao, H. M. Soo, W. Wu, Z. Zhang, Z. Wen, D. P. Lane, and J. Peng
Loss of function of def selectively up-regulates {Delta}113p53 expression to arrest expansion growth of digestive organs in zebrafish
Genes & Dev., December 1, 2005; 19(23): 2900 - 2911.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Yue, T. Daikoku, X. Hou, M. Li, H. Wang, H. Nojima, S. K. Dey, and S. K. Das
Cyclin G1 and Cyclin G2 Are Expressed in the Periimplantation Mouse Uterus in a Cell-Specific and Progesterone-Dependent Manner: Evidence for Aberrant Regulation with Hoxa-10 Deficiency
Endocrinology, May 1, 2005; 146(5): 2424 - 2433.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Korgaonkar, J. Hagen, V. Tompkins, A. A. Frazier, C. Allamargot, F. W. Quelle, and D. E. Quelle
Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function
Mol. Cell. Biol., February 15, 2005; 25(4): 1258 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
C.J. SHERR, D. BERTWISTLE, W. DEN BESTEN, M.-L. KUO, M. SUGIMOTO, K. TAGO, R.T. WILLIAMS, F. ZINDY, and M.F. ROUSSEL
p53-Dependent and -Independent Functions of the Arf Tumor Suppressor
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 129 - 137.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S. G.J. van Breda, E. van Agen, L. G.J.B. Engels, E. J.C. Moonen, J. C.S. Kleinjans, and J. H.M. van Delft
Altered vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from adenoma patients and controls
Carcinogenesis, November 1, 2004; 25(11): 2207 - 2216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, N. Li, C. Wang, Y. Yu, L. Yuan, M. Zhang, and X. Cao
Cyclin L2, a Novel RNA Polymerase II-associated Cyclin, Is Involved in Pre-mRNA Splicing and Induces Apoptosis of Human Hepatocellular Carcinoma Cells
J. Biol. Chem., March 19, 2004; 279(12): 11639 - 11648.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Bertwistle, M. Sugimoto, and C. J. Sherr
Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23
Mol. Cell. Biol., February 1, 2004; 24(3): 985 - 996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.